Australia markets closed

SAVA Nov 2024 35.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
1.0000-0.1500 (-13.04%)
At close: 01:07PM EDT
Full screen
Previous close1.1500
Expiry date2024-11-15
Day's range1.0000 - 1.3500
Contract rangeN/A
Open interest184
  • Yahoo Finance Video

    Cassava forms committee after US probe, researcher fraud

    Cassava Sciences (SAVA) is reportedly forming a committee to investigate two senior employees. This comes after a US probe into fraud and a Cassava researcher was indicted by a jury over alleged fabrication of Alzheimer's drug trial results. For more expert insight and the latest market action, click here to watch this full episode of Market Domination. This post was written by Luke Carberry Mogan.


    Cassava Sciences Shares Plunge on Indictment Against Former Advisor

    A federal indictment accuses a Cassava Sciences advisor of faking data to secure NIH grants. The company also faces shareholder suits.

  • GlobeNewswire

    Cassava Sciences Issues Statement on Former Science Advisor

    AUSTIN, Texas, June 28, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), reported it has learned today that a federal grand jury returned an indictment charging Hoau-Yan Wang for allegedly defrauding the U.S. National Institutes of Health (NIH). Hoau-Yan Wang was a tenured medical professor at a public university’s medical school as well as a former paid science advisor to Cassava Sciences. According to public court documents, Dr. Wang engaged in illegal behavior to defraud the go